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Abstract We have expressed the catalytic domain of Chinese
hamster HMG-CoA reductase, and 13 point mutations involving
the region around the single phosphorylation site for AMP-
activated protein kinase. After phosphorylation, these were used
to test the specificity of isoforms of protein phosphatase-2A
[bovine PP2A
C
(catalytic subunit) and PP2A
1
(ABC hetero-
trimer)] and protein phosphatase-2C (human K; mouse K, L1, L2,
L3, L4, L5). PP2A
1
had s 50-fold higher activity for HMG-CoA
reductase variants than PP2A
C
, but their relative selectivity for
different variants was similar. Although the specificities of PP2A
and PP2C were distinct, no dramatic differences in selectivity
were observed between different PP2C isoforms.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
The serine/threonine-speci¢c protein phosphatases (PP) in
eukaryotic cells can be divided into two distinct families which
are not related in sequence: (i) the PPP family, including the
PP1, PP2A and PP2B subfamilies; (ii) the PPM family, in-
cluding the PP2C subfamily [1]. PP2A holoenzymes comprise
a 36 kDa catalytic (C) subunit complexed with an A subunit
(PR65) and one of several B subunits (e.g. PR55) [2]. The
enzyme is thought to be an ABC heterotrimer in vivo,
although free AC dimer may also exist. Two isoforms of
PP2C (K and L) have been de¢ned by amino acid [3] and
DNA sequencing [4^7]. In addition, mouse PP2CL exists as
¢ve variants (L1 to L5) which appear to be generated by
alternative splicing [8,9]. Unlike PP2A, PP2Cs are monomers,
at least in mammals.
By contrast with protein kinases [10], much less is known
about how protein phosphatases recognize their target pro-
teins. Some features of the speci¢city of members of the
PP1, PP2A and PP2C subfamilies have been deduced using
synthetic peptide substrates [11^13]. However, it has proved
di¤cult to correlate recognition determinants derived from
synthetic peptide studies with the speci¢city of these phospha-
tases for protein substrates. One reason might be that protein
phosphatases recognize secondary or tertiary structure rather
than simple primary sequence determinants. Therefore specif-
icity studies performed using mutations of a native protein
might be more informative than those performed using syn-
thetic peptides. We have recently expressed the catalytic do-
main of Chinese hamster 3-hydroxy-3-methylglutaryl-CoA
(HMG-CoA) reductase in Escherichia coli, and studied the
speci¢city of rat AMP-activated protein kinase (AMPK) using
the wild-type protein and several point mutations at or near
the single phosphorylation site [14]. We have now used the
phosphorylatable variants to study the speci¢city of the free
catalytic subunit and heterotrimer forms of PP2A, human
PP2CK, and the K, L1, L2, L3, L4 and L5 isoforms of mouse
PP2C.
2. Material and methods
2.1. Materials
Histidine-tagged HMG-CoA reductase mutants were expressed in
E. coli and puri¢ed to homogeneity [14]. AMPK was puri¢ed from rat
liver as far as the gel ¢ltration step [15] and was a mixture of the K1
and K2 isoforms [16]. Human PP2C-a was expressed and puri¢ed
from E. coli [17]. PP2A catalytic subunit and ABC heterotrimer forms
were puri¢ed from bovine heart and rabbit skeletal muscle [18].
Expression constructs for mouse PP2Cs were made from the plas-
mids pKMC-PP2CK [7], pKMC-MPP L-1 and L-2 [9] and TK-3,
4 and 5 [8]. NcoI-EcoRI fragments were cloned in the correct reading
frame into pGEX-2T. The plasmids were used to transform E. coli
DH5K, expression being in 300 ml cultures for 5 h at 30³C in 100 WM
isopropylthiogalactoside. Cells were collected by centrifugation and
lysed by sonication in 3 ml ice-cold phosphate-bu¡ered saline (PBS)
containing 1 WM phenylmethane sulphonyl£uoride. Triton X-100 (1%,
v/v) was added and the suspension centrifuged (10 000Ug ; 10 min).
Glutathione-agarose (200 Wl, 50% (v/v) suspension) was added to the
supernatant, incubated in a rotary shaker for 15 min at 4³C, and the
beads packed into a column. The column was washed with 12 ml of
PBS plus Triton X-100 (1%, v/v), then 4 ml of 50 mM Tris/HCl, pH
7.5, 150 mM NaCl, then 4 ml of the same bu¡er plus 2.5 mM CaCl
2
(cleavage bu¡er). The glutathione-agarose was removed from the col-
umn, incubated in 300 Wl cleavage bu¡er containing thrombin (Sigma,
10 Wg/ml) for 1 h at 25³C, and the suspension centrifuged (200Ug ; 10
s). The PP2C isoforms in the supernatant were stored at 370³C.
2.2. Preparation of phosphosubstrates, protein phosphatase assays and
other procedures
HMG-CoA reductase (200 Wg/ml), AMPK (0.8 U/ml), AMP (200
WM), MgCl
2
(5 mM) and [Q-
32
P]ATP (200 WM, 500^1000 dpm/pmol)
were incubated for 30 min at 30³C. ATP was removed by centrifuging
the sample through a Sephadex G-50 Nick Spin column equilibrated
in 1 M imidazole, 500 mM NaCl, 20 mM Tris/HCl, pH 7.5. Protein
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phosphatase assays (30 Wl) contained 10 Wl of protein phosphatase in
Tris/HCl (50 mM, pH 7.5), EGTA (0.1 M), 2-mercaptoethanol
(0.03%, v/v), bovine serum albumin (0.33 mg/ml), Brij-35 (0.01%, w/
v). The reaction was started by adding [
32
P]HMG-CoA reductase to
2.6 WM ¢nal, and after incubation at 30³C the reaction was stopped
by adding 200 Wl of trichloroacetic acid (20%, w/v). The precipitate
was removed by centrifugation (14 000Ug, 3 min) and 200 Wl of the
supernatant was counted in 1 ml of scintillant. At least 3 time points
were measured to ensure that initial rates were being measured.
Protein concentration was measured by the method of Bradford
[19]. SDS-polyacrylamide gel electrophoresis was by the method of
Laemmli [20].
3. Results
3.1. Characterization of phosphorylated HMG-CoA reductase
and protein phosphatases
All protein phosphatases used in this study were homoge-
neous by SDS-PAGE (Fig. 1; not shown for mouse PP2Cs).
PP2A
C
consisted of the 36 kDa catalytic subunit (C36) only,
whereas PP2A
1
contained equimolar amounts of the A
(PR65), B (PR55) and C subunits. All expressed PP2C iso-
forms contained a single catalytic subunit of 42^45 kDa. The
advantages of using the expressed catalytic domain of HMG-
CoA reductase (HMG
C
) as the substrate in this study were
twofold: (i) it is phosphorylated stoichiometrically by AMPK
at a single de¢ned site (corresponding to Ser-871 in the com-
plete sequence) [14]; (ii) phosphorylated HMG-CoA reductase
is one of the best-known protein substrates for PP2C in vitro
[21]. Using PP2A
C
, there was an excellent correlation between
removal of [
32
P]phosphate from HMG
C
and recovery of
HMG-CoA reductase activity, and on extrapolation to 100%
dephosphorylation the HMG-CoA reductase activity returned
to that of a non-phosphorylated control (not shown).
3.2. Dephosphorylation of mutant HMG-CoA reductases by
PP2A isoforms and PP2CK
We compared the initial rates of dephosphorylation of var-
ious forms of HMG-CoA reductase which had point muta-
tions at or around the phosphorylation site, Ser-871 (Fig. 2).
In general the mutants were dephosphorylated at similar rates
to the wild type, notable exceptions being: (i) PP2A
C
and PP2A
1
(but not PP2CK) greatly preferred phosphothreonine
over phosphoserine (11-fold and 6-fold, respectively); (ii)
PP2A
C
and PP2A
1
(but not PP2CK) dephosphorylated the
R870A mutant W3-fold more rapidly than the wild type;
(iii) the K872E mutant was dephosphorylated 4-fold more
slowly than the wild type by PP2CK. In Fig. 2 the rates are
expressed relative to the rates obtained using wild-type HMG-
CoA reductase, and using this method of presentation the
speci¢cities of PP2A
C
and PP2A
1
appear very similar,
although PP2A
C
did have a stronger preference for phospho-
threonine over phosphoserine. However, if the results are ex-
pressed as absolute rates per mole of phosphatase (Table 1), it
can be seen that PP2A
C
dephosphorylated all forms of HMG-
CoA reductase much more slowly than PP2A
1
or PP2CK.
Using wild-type HMG
C
, dephosphorylation by PP2A
1
was
87-fold faster, and by PP2CK was 30-fold faster, than dephos-
phorylation by PP2A
C
. On average, PP2A
1
dephosphorylated
the 14 HMG-CoA reductase variants 73þ 19-fold (meanþ
standard deviation) faster than PP2A
C
.
Attempts to measure more detailed kinetic parameters were
not successful. With each of the three phosphatases and wild-
type HMG
C
as substrate, there was little sign of saturation of
the rate at substrate concentrations as high as 50 WM. It was
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Fig. 2. Initial rate of dephosphorylation of HMG-CoA reductase
variants by PP2A
C
, PP2A
1
and human PP2CK. The results are ex-
pressed relative to the rate obtained with wild-type HMG
C
. A ¢xed
concentration of HMG-CoA reductase (2.6 WM) was used in every
case, and the results are the meanþ standard error of the mean for
3 separate experiments.
Fig. 1. SDS-polyacrylamide gel electrophoresis of puri¢ed bovine
heart PP2A
C
and PP2A
1
, and human PP2C (K isoform). The gel
was stained with Coomassie Blue, and the migration of molecular
mass markers is shown at left.
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not feasible to use the substrates at concentrations higher than
this.
3.3. Dephosphorylation of mutant HMG-CoA reductases by
mouse PP2CK and ¢ve splice variants of PP2CL
Recently, cDNAs encoding the L isoform of mouse PP2C
has been shown to exist as ¢ve variants which would give rise
to distinct amino acid sequences (L1 through L5), apparently
due to alternative splicing of a single gene product. To exam-
ine whether these isoforms exhibited any di¡erences in sub-
strate speci¢city, we used wild-type HMG
C
and two of the
mutants to examine their speci¢city. In Fig. 3 the results are
expressed as moles phosphate released per mole PP2C per
second. The results con¢rmed that human PP2C showed no
preference for phosphothreonine over phosphoserine. Surpris-
ingly, all six mouse isoforms did show a moderate preference
for phosphothreonine, with S871T being dephosphorylated at
a rate 2- to 4-fold faster than the wild type. Substitution of a
glutamic acid for the lysine at the +1 position (K872E mu-
tant) had a moderately deleterious e¡ect on dephosphoryla-
tion by all human and mouse PP2C isoforms.
4. Discussion
In general, the results obtained in this study using native
protein substrates based on HMG-CoA reductase are in qual-
itative agreement with those obtained previously using syn-
thetic peptide substrates [11^13]. In most cases substitution
of amino acids within ¢ve residues of the phosphoamino
acid had only moderate e¡ects on dephosphorylation by
PP2A
C
, PP2A
1
or PP2C. The most striking di¡erences be-
tween wild-type and mutant HMG-CoA reductases are dis-
cussed below:
1. Both PP2A
C
(11-fold) and PP2A
1
(6-fold) exhibited
marked preferences for HMG-CoA reductase containing
phosphothreonine (Tp), rather than phosphoserine (Sp) in
the same sequence context. A similar preference has been
noted previously using synthetic peptide substrates with vari-
ous forms of PP2A [11,12], and using a protein substrate
(MAP kinase kinase, MAPKK1) with PP2A
1
[22].
2. Using the synthetic peptides RRATpVA and RRASpVA,
rabbit PP2C (a mixture of K and L isoforms) has also been
found to have a strong (30-fold) preference for phosphothreo-
nine over phosphoserine [13]. Surprisingly, with HMG-CoA
reductase variants as substrates human PP2CK did not exhibit
any such preference, although mouse PP2CK and ¢ve iso-
forms of mouse PP2CL did exhibit a moderate (2- to 4-fold)
preference. Whether these discrepancies represent genuine spe-
cies di¡erences, or whether they are connected with the meth-
od of expression and/or puri¢cation of the PP2C isoforms, is
not clear.
3. Replacement of the arginine at the P-1 position on
HMG-CoA reductase with alanine (R870A) had no e¡ect
on human PP2CK, but caused a W3-fold increase in the
rate of dephosphorylation by both PP2A
C
and PP2A
1
(Fig.
2). A deleterious e¡ect for PP2A of a basic residue at this
position does not appear to have been reported previously.
In the crystal structure for PP1Q, the active site where the
phosphate group binds is located in a small pocket, and there
are two basic residues (Arg-96 and Arg-221) on the outer edge
of this pocket [23]. These arginines are conserved in PP2A,
and it is possible that they contribute to the negative e¡ect of
an arginine at the P-1 position on the substrate.
4. Replacement of the lysine at the P+1 position by gluta-
mic acid (K872E) had no signi¢cant e¡ect on dephosphoryla-
tion by either form of PP2A, but reduced the rate of dephos-
phorylation by all forms of PP2C by up to 4-fold. This is
consistent with previous ¢ndings that RRSTpEA was dephos-
phorylated s 10-fold more slowly than RRSTpVA by a mix-
ture of rabbit PP2CK and PP2CL [13], although the e¡ect was
smaller with the native protein rather than the peptide sub-
strate. The present work shows that it is the negative charge
that has the deleterious e¡ect, since there was no di¡erence in
the rate of dephosphorylation of the wild type and the K872A
mutant. In the structure for human PP2CK, the catalytic site
is in a deep channel, the £oor of which is lined with acidic
residues, including Glu-37, Asp-239 and Asp-243 [24]. This
may account for the inhibitory e¡ect of an acidic residue
located at the P+1 position on the substrate. HMG-CoA re-
ductase may make more contacts with PP2C than short pep-
tides, so that the inhibitory e¡ect of an acidic residue at P+1 is
less marked with the protein substrate.
One thing that is clear from this study is that the speci¢c-
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Table 1
Initial rates of dephosphorylation of HMG-CoA reductase variants,
expressed as mmoles phosphate released per mole of protein phos-
phatase per second at 30³C (meanþ standard error of the mean for
three determinations)
Variant PP2AC PP2A1 PP2C
WT 2.67þ 0.04 231þ 12 81.0þ 2.6
H868A 3.57þ 0.11 248þ 29 100.0þ 8.4
H868K 1.31þ 0.03 129þ 2 49.0þ 3.3
H868P 2.29þ 0.15 90þ 8 55.0þ 1.5
H868R 1.72þ 0.08 181þ 25 50.0þ 3.8
K872A 3.90þ 0.08 212þ 8 80.0þ 1.4
K872E 3.41þ 0.23 273þ 18 21.0þ 1.1
L875V 3.16þ 0.12 188þ 13 90.0þ 0.8
M866A 2.27þ 0.28 182þ 11 60.0þ 3.3
M866L 2.33þ 0.23 161þ 6 86.0þ 6.7
M866V 2.39þ 0.16 216þ 21 64.0þ 1.0
R870A 9.13þ 0.40 631þ 14 103.0þ 2.1
S871T 29.10þ 0.83 1424þ 51 90.0þ 1.2
H868R/K872A 1.91þ 0.02 137þ 5 32.0þ 2.2
All variants were at a ¢xed substrate concentration of 2.6 WM. PP2C
was the human K isoform.
Fig. 3. Initial rate of dephosphorylation of the wild type and the
S871T and K872E variants of HMGC by PP2C isoforms. The re-
sults are expressed as moles phosphate released per mole phospha-
tase per second at 30³C: this is not a true turnover number since a
single arbitrary substrate concentration (2.6 WM) was used. K
H
, K
M
,
human and mouse K isoforms; L-1...L-5, mouse L isoforms.
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ities of both PP2A and PP2C are di¡erent from those of
AMPK. Mutants of HMG-CoA reductase which do not
have a bulky hydrophobic residue at the P-5 position
(M866A) or a basic residue at the P-4 position (H868A) are
very poor substrates for AMPK [14], but these changes are
neutral with respect to dephosphorylation by PP2A or PP2C
(Fig. 2).
The relative speci¢cities of PP2A
C
and PP2A
1
for di¡erent
HMG-CoA reductase variants (i.e. expressing the rates rela-
tive to those obtained with wild-type HMG-CoA reductase)
are not markedly di¡erent (Fig. 2). However, the absolute
rates of dephosphorylation are dramatically di¡erent (Table
1). PP2A
1
dephosphorylated all HMG-CoA reductase var-
iants from 40- to 100-fold more rapidly than PP2A
C
. Clearly
the free catalytic subunit of PP2A is a very poor HMG-CoA
reductase phosphatase, and the presence of the A and B sub-
units has a dramatic e¡ect on the absolute rate, but not on the
selectivity for di¡erent HMG-CoA reductase variants. Large
e¡ects of the A and/or B subunits on selectivity for speci¢c
protein substrates have been reported before (reviewed in
[25]). Our results are consistent with the idea that the A and
B subunits can have a marked e¡ect on initial binding of a
protein substrate to the phosphatase, although recognition of
the area immediately around the phosphorylation site seems
to be a function of the C subunit alone.
The di¡erent PP2C isoforms utilized in the present study do
not di¡er markedly in speci¢city from one another. This is not
perhaps surprising, since the mouse K and L are 80% identical
within the catalytic domain, while the di¡erences between the
¢ve mouse L isoforms all occur in the C-terminal region out-
side of the conserved catalytic domain [8].
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